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Michael J. Lawrence

2A The Problem: Vermonters are still smoking.
▪ According to the 2019 Vermont Tobacco Pages update:1
▪
▪
▪
▪

17% of Vermont adults are smokers (vs. 14% of adults nationwide)
20th: Vermont state rank in adult smoking prevalence nationwide2
8/14 counties have ≥20% prevalence of adult smoking
Areas served by Newport and Springfield hospitals have the greatest prevalence in the
state (24% and 27%, respectively).

▪ These data suggest opportunity for further intervention, both statewide and
locally, and within healthcare institutions as well.

1. 2017 Vermont Tobacco Pages, Vermont Department of Health.
2. Campaign for Tobacco-Free Kids, “The Toll of Tobacco in the US,” (2019), available at https://www.tobaccofreekids.org/problem/toll-us

2B The Problem, part 2: low awareness of
genitourinary effects of smoking
▪ Smoking is the #1 risk factor in developing urothelial carcinoma of the
bladder. Quitting reduces that risk:3,4
▪ Current smokers: Hazard ratio 3.89 in men, 4.65 in women
▪ Former smokers: Hazard ratio 2.07 in men, 2.89 in women

▪ Heavier smoking also correlates with more aggressive bladder cancer.5
▪ Erectile dysfunction and CVD share many risk factors, including smoking.

▪ Cessation produced significant improvement in ED within a month in one prospective
cohort study.6

▪ Smoking concurrence with prostate cancer has been linked with greater risk
of mortality, metastasis, and recurrence.7,8
▪ Even among urology patients, there is generally low awareness of smokingrelated genitourinary disease9 - an opportunity to educated and incentivize
patients to quit.
3. Freedman et al., "Association between smoking and risk of bladder cancer among men and women." JAMA 306, no. 7 (2011): 737-745.
4. Cumberbatch et al., "The role of tobacco smoke in bladder and kidney carcinogenesis: a comparison of exposures and meta-analysis of incidence and mortality risks." European urology 70, no. 3 (2016): 458-466.
5. Pietzak et al. "Heavy cigarette smoking and aggressive bladder cancer at initial presentation." Urology 86, no. 5 (2015): 968-973.
6. Guay et al., "Cessation of smoking rapidly decreases erectile dysfunction." Endocrine Practice 4, no. 1 (1998): 23-26.
7. Islami et al., "A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies." European urology 66, no. 6 (2014): 1054-1064.
8. Foerster et al.,"Association of smoking status with recurrence, metastasis, and mortality among patients with localized prostate cancer undergoing prostatectomy or radiotherapy: a systematic review and meta-analysis." JAMA oncology 4, no. 7 (2018): 953-961.
9. Bjurlin et al., "Ethnicity and smoking status are associated with awareness of smoking related genitourinary diseases." The Journal of urology 188, no. 3 (2012): 724-728.

3A Public Health Costs of Tobacco Use
▪ According to the Vermont Tobacco Control State Plan, 2015-2020:10
▪ $348 million per year: amount Vermonters spend on tobacco-related healthcare
▪ 1000: tobacco-related deaths per year
**Unfortunately, no public data on the cost of genitourinary disease to Vermonters could be
found, and calls placed to the Vermont Department of Health were not returned.

10. Vermont Department of Health, Vermont Tobacco Control State Plan, 2015-2020: Collaborating to Reduce Tobacco Use for a Healthier Vermont

3B. Public Health Burden of Genitourinary
Disease
Prostate and bladder cancer are among the top 5 cancers in incidence and mortality
affecting Vermont men:11
Incidence

11. Vermont Department of Health, 2016-2020 Vermont Cancer Plan: A Framework for Action: 5

Mortality

4A Community Perspective on Smoking and
12
Resources for Quitting
▪ Viki Delmas, Vermont Quit Partner (CVMC):
▪ COVID-19 has simultaneously created greater incentive to quit and greater levels of
stress leading to more relapses.
▪ With more people at home, there’s more flexibility with getting them resources they
need.

▪ Nancy Wagner, RDN, CDC, CHC, TTS (CVMC):
▪ Resources:
▪ 802Quits provides 8 weeks of free nicotine replacement per year
▪ The Blueprint Grant allowed for unlimited group and one-on-one counseling sessions that would normally
be limited by insurance coverage -> this grant is disappearing soon.

▪ Access to resources is NOT the issue in lowering smoking rates in VT. It’s patient
motivation. 90% is the habit; 10% is the nicotine addiction.
▪ Anything to drive that motivation would be beneficial, including education about
genitourinary effects.
12. Remarks above are paraphrased from interviews conducted via telephone and are not direct quotations.

4B Community Perspective on Smoking-Related
Genitourinary Disease Incentivization to Quit13
• Brian Rodriguez, MD (CVMC Family Medicine):
• Using prostate and bladder cancer to incentivize quitting smoking is a good idea. Lots of
patients don’t realize the connection between the two.
• The same is true for ED. It’s a blood flow issue, and smoking makes it worse. I often use
that to try to get male patients to quit.

13. Remarks above are paraphrased from an in-person discussion and are not direct quotations.

5. Intervention & Methodology
▪ Intervention: patient education materials
▪ Medium: poster
▪ Content: information regarding genitourinary effects of smoking in men, with an
entertaining, traditionally male-centric theme
▪ Rationale: an eye-catching poster with a theme catering towards one sex may be more effective
than a gender-neutral poster aimed at both sexes

▪ Location: to be displayed in patient bathrooms in healthcare practices
▪ Rationale: discreet location for relaying information about intimate/private body system; patient
bathrooms tend to be minimally adorned with decorations/other materials, allowing for
maximum impact and minimum distraction

▪ Duration: to be displayed at the discretion of practice manager and medical director

6 Results & Response
▪ Informal pilot survey: prior to the creation of the final draft of the poster
and its display, a small number of actively smoking male patients (n=4) were
offered brief counseling on genitourinary effects of smoking.
▪ All were receptive to the information; two expressed no prior knowledge of
these effects.

7 Effectiveness & Limitations
▪ Effectiveness:
▪ Patients and providers appeared to be receptive and appreciative of the poster’s design
▪ One patient expressed appreciation that the poster had “personality” which is “rare in
this kind of [educational] stuff ”
▪ The poster immediately attracts attention in the bathroom, especially in the absence of
other distracting materials or decorations

▪ Limitations:
▪ Information only reaches patients who use the bathroom
▪ Passive form of education; direct communication from physician would likely have more
impact
▪ Still requires significant action on the part of the patient (e.g. “Ask your doctor…”)
▪ No mechanism in place for evaluating efficacy

8 Recommendations for Future Projects
▪ In general, continue to make materials targeted for specific populations,
with themes that appeal/speak to those groups
▪ Design formal survey that evaluates current patient knowledge of
genitourinary effects of smoking. Repeat survey in 12 months to evaluate
penetrative power of educational poster
▪ If significant improvement in patient knowledge: identify another demographic for
targeted smoking cessation education/therapy and repeat process
▪ If no significant improvement: re-evaluate poster design, location, and content
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